|
Peter Schoevers is CEO of Julius Clinical Research.
He has a degree in Business Administration from the State University of Groningen, the Netherlands, and followed an executive MBA course at IMD, Lausanne, Switzerland. He also followed the EU Executive Training Program in Japan, a full-time post-doctoral program, containing intensive study of Japanese language and business culture and in-house training in two Japanese corporations.
Peter Schoevers worked for Solvay Pharmaceuticals for 10 years in international management positions in the Netherlands, UK, Germany, Belgium and Japan. In his last position he was director of operations for Solvay Pharmaceuticals in Japan. For the last 10 years, Peter Schoevers co-founded a number of life sciences companies including Julius Clinical Research.
|
